Add to ORKGA large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillanc
Ding-Wei Ye, Hai-Liang Zhang 1Department of Urology, Fudan University Shanghai Cancer Center, 2Depar...
JOURNAL ARTICLE;The emergence of novel drugs corresponds with the determination of the effectiveness...
Sorafenib was FDA approved in 2005 for treatment of renal cell carcinoma (RCC) based on the results ...
A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unr...
Objective: Effects of sorafenib in general clinical practice, especially those with patients of Asia...
Objective To evaluate the efficacy and safety of sorafenib for Korean patients with metastatic renal...
Objective: To assess the efficacy and safety of everolimus in Japanese patients with meta-static ren...
Objective: Effects of sorafenib in general clinical practice, especially those with patients of Asia...
To evaluate the efficacy and safety of sorafenib for Korean patients with metastatic renal cell carc...
The Author(s) 2015. This article is published with open access at Springerlink.com Background Sorafe...
Copyright © 2015 Chun-hua Lin et al. This is an open access article distributed under the Creative C...
Sorafenib has been recommended as first- or second-line treatment for metastatic renal cell carcinom...
Background: This registrational trial evaluated the efficacy, safety, and patient-reported outcomes ...
To evaluate the efficacy and safety of sorafenib for Korean patients with metastatic renal cell carc...
Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic re...
Ding-Wei Ye, Hai-Liang Zhang 1Department of Urology, Fudan University Shanghai Cancer Center, 2Depar...
JOURNAL ARTICLE;The emergence of novel drugs corresponds with the determination of the effectiveness...
Sorafenib was FDA approved in 2005 for treatment of renal cell carcinoma (RCC) based on the results ...
A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unr...
Objective: Effects of sorafenib in general clinical practice, especially those with patients of Asia...
Objective To evaluate the efficacy and safety of sorafenib for Korean patients with metastatic renal...
Objective: To assess the efficacy and safety of everolimus in Japanese patients with meta-static ren...
Objective: Effects of sorafenib in general clinical practice, especially those with patients of Asia...
To evaluate the efficacy and safety of sorafenib for Korean patients with metastatic renal cell carc...
The Author(s) 2015. This article is published with open access at Springerlink.com Background Sorafe...
Copyright © 2015 Chun-hua Lin et al. This is an open access article distributed under the Creative C...
Sorafenib has been recommended as first- or second-line treatment for metastatic renal cell carcinom...
Background: This registrational trial evaluated the efficacy, safety, and patient-reported outcomes ...
To evaluate the efficacy and safety of sorafenib for Korean patients with metastatic renal cell carc...
Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic re...
Ding-Wei Ye, Hai-Liang Zhang 1Department of Urology, Fudan University Shanghai Cancer Center, 2Depar...
JOURNAL ARTICLE;The emergence of novel drugs corresponds with the determination of the effectiveness...
Sorafenib was FDA approved in 2005 for treatment of renal cell carcinoma (RCC) based on the results ...